Methadone adverse reaction presenting with large increase in plasma methadone binding: a case series

Por Lu, Wenjie J, Zhou, Weidong, Kreutz, Yvonne, Flockhart, David A
Publicado em 2011

Efavirenz-mediated induction of omeprazole metabolism is CYP2C19 genotype-dependent

Por Michaud, Veronique, Kreutz, Yvonne, Skaar, Todd, Ogburn, Evan, Thong, Nancy, Flockhart, David A., Desta, Zeruesenay
Publicado em 2013

Morbid obesity and metabolic syndrome in Ossabaw miniature swine are associated with increased platelet reactivity

Por Kreutz, Rolf P, Alloosh, Mouhamad, Mansour, Khaled, Neeb, Zachary, Kreutz, Yvonne, Flockhart, David A, Sturek, Michael
Publicado em 2011

Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin

Por KREUTZ, ROLF P., NYSTROM, PERRY, KREUTZ, YVONNE, MIAO, JIA, KOVACS, RICHARD, DESTA, ZERUESENAY, FLOCKHART, DAVID A., JIN, YAN
Publicado em 2012

Platelet Factor XIIIa Release During Platelet Aggregation and Plasma Clot Strength Measured by Thrombelastography in Patients with Coronary Artery Disease Treated with Clopidogrel

Por Kreutz, Rolf P., Owens, Janelle, Lu, Deshun, Nystrom, Perry, Jin, Yan, Kreutz, Yvonne, Desta, Zeruesenay, Flockhart, David A.
Publicado no Platelets (2014)

Protease Activated Receptor-1 (PAR-1) Mediated Platelet Aggregation is Dependant on Clopidogrel Response

Por Kreutz, Rolf P., Breall, Jeffrey A., Kreutz, Yvonne, Owens, Janelle, Lu, Deshun, Bolad, Islam, von der Lohe, Elisabeth, Sinha, Anjan, Flockhart, David A.
Publicado em 2012

Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response

Por Kreutz, Rolf P, Nystrom, Perry, Kreutz, Yvonne, Miao, Jia, Desta, Zeruesenay, Breall, Jeffrey A, Li, Lang, Chiang, ChienWei, Kovacs, Richard, Flockhart, David A, Jin, Yan
Publicado em 2012

Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel response

Por Kreutz, Rolf P, Owens, Janelle, Jin, Yan, Nystrom, Perry, Desta, Zeruesenay, Kreutz, Yvonne, Breall, Jeffrey A, Li, Lang, Chiang, ChienWei, Kovacs, Richard J, Flockhart, David A
Publicado em 2013

Efavirenz inhibits the human ether-a-go-go related current (hERG) and induces QT interval prolongation in CYP2B6*6*6 allele carriers

Por Abdelhady, Ahmed M., Shugg, Tyler, Thong, Nancy, Li Lu, Jessica Bo, Kreutz, Yvonne, Jaynes, Heather A., Robarge, Jason D., Tisdale, James E., Desta, Zeruesenay, Overholser, Brian R.
Publicado no J Cardiovasc Electrophysiol (2016)